Baidu
map

Cancer:结婚益处多多 可改善癌症生存率且帮助延年益寿

2016-04-13 佚名 生物谷

一项刊登在国际杂志Cancer上的研究论文中,来自加州癌症预防学会的研究人员表示,结婚戒指或许是抵御癌症的强大药物,研究者在文章中指出,对于癌症而言,已婚人士似乎拥有显著的生存优势,相比已经结婚的男性患者而言,单身的男性癌症患者的死亡率要高于前者27%,而单身女性癌症患者的死亡率要高于已婚女性死亡率的19%。 文章作者Scarlett Li

图片来源:medicalxpress.com

-一项刊登在国际杂志Cancer上的研究论文中,来自加州癌症预防学会的研究人员表示,结婚戒指或许是抵御癌症的强大药物,研究者在文章中指出,对于癌症而言,已婚人士似乎拥有显著的生存优势,相比已经结婚的男性患者而言,单身的男性癌症患者的死亡率要高于前者27%,而单身女性癌症患者的死亡率要高于已婚女性死亡率的19%。

文章作者Scarlett Lin Gomez说道,我们发现的这种效应非常显著,过去10至15年的研究结果表明,婚姻对于癌症患者也存在类似的效应,而这种效应总是因为已婚人士的配偶给予的支持和关爱。但已婚个体更趋向于有较高的混合性收入和更好的保险体系,为此研究人员决定进一步研究来揭示是否金钱在已婚配偶的生存率上扮演着重要角色。

研究人员分析了来自加州80万名个体的健康记录,这些个体在2000至2009年间均被诊断出患有侵袭性的癌症,而且研究者对这些个体一直追踪观察到2012年;研究者表示,财力状况对个体击败癌症的机会并不具有一定影响,反而来自配偶的关怀和支持是癌症患者获益且提高生存率的关键,比如带着他/她去定期进行检查,给对方准备一顿营养的餐食,并且提醒对方按时服药等。

已婚的癌症患者往往会从情感上的支持获益,而这会减少患者的压力并且改善患者疾病进展的步伐;Gregory Masters博士说道,致力于护理事业的价值或许对于改善癌症病人的生存率非常有必要,本文研究结果或许并不是仅对于改善癌症患者的生存有效,我们都知道不论疾病困扰,当两个人结为伴侣共同生活扶持,他们或许也会变得比较长寿。

研究者表示,结婚对个体生存的有益影响或许在各种族人群中都表现不同,白人或许会因结婚获益较多,而西班牙裔的美国人和太平洋岛居民或许获益较少,而出生在美国的西班牙裔的美国人和太平洋岛居民相比出生在国外的个体而言获益的程度又会增加。

原始出处:

Scarlett Lin Gomez,et al.Effects of marital status and economic resources on survival after cancer: A population-based study.Cancer.11 APR 2016.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-27 1dd8c52fm63(暂无匿称)

    结婚?发昏!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 李继凯

    高大上的文章

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 李继凯

    值得学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 chenchuny

    为婚姻有找到新的yan

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1945811, encodeId=585f194581181, content=<a href='/topic/show?id=21fde1416b9' target=_blank style='color:#2F92EE;'>#癌症生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71416, encryptionId=21fde1416b9, topicName=癌症生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Oct 28 17:37:00 CST 2016, time=2016-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951401, encodeId=f6b61951401dd, content=<a href='/topic/show?id=637349503a9' target=_blank style='color:#2F92EE;'>#延年益寿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49503, encryptionId=637349503a9, topicName=延年益寿)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sat Oct 22 08:37:00 CST 2016, time=2016-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83056, encodeId=949e8305633, content=结婚?发昏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Apr 27 09:51:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256534, encodeId=9f7512565346d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Fri Apr 15 00:37:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77921, encodeId=38dee7921f3, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77922, encodeId=46e9e792258, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:00:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77787, encodeId=be8de77873c, content=为婚姻有找到新的yan, beContent=null, objectType=article, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Thu Apr 14 09:47:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77752, encodeId=fb07e77520a, content=癌症的生存率,也是临床医生努力的方向。, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 14 00:23:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 Lisa971

    癌症的生存率,也是临床医生努力的方向。

    0

相关资讯

Science子刊:癌症药物或可用来治疗血管变形疾病

日前发表在国际著名杂志Science Translational Medicine上的一项研究论文中,来自斯隆凯德琳癌症纪念研究中心(Memorial Sloan-Kettering)等机构的研究人员通过研究发现,一种当前在癌症患者中进行试验的药物或可被用于治疗血管畸形病。 文章中,研究者对基因PIK3CA突变的小鼠进行工程化操作,PIK3CA基因和癌症发病直接相关,随后这些小鼠机体中出现了静

Cell Metab:肥胖为何诱发糖尿病?科学家找到重要“推手”

本文亮点: 高脂饮食会增加附睾旁脂肪组织内的NK细胞数目并促进NK细胞激活 附睾旁脂肪组织内的NK细胞能够调节肥胖模型中脂肪组织巨噬细胞介导的炎症 脂肪组织内的NK细胞能够调节肥胖诱导的胰岛素抵抗进展 最近,来自哈佛大学医学院的研究人员在国际学术期刊cell metabolism上发表了一项最新研究进展,他们发现附睾旁脂肪组织内的自然杀伤细胞(NK细胞)能够通过影响脂肪组织巨噬细胞介

Front Aging Neurosci:模拟运动或可改善阿尔兹海默氏症患者的病情

据美国阿尔兹海默氏症协会数据显示,阿尔兹海默氏症是引发美国人死亡的第六大原因,目前并没有有效的疗法和途径来减缓或抑制患者的病情进展,但患者可以通过机体和认知康复来获益,而且研究者目前也正在研究是否模仿行为可以作为一种有效工具来帮助重拾患者失去的能力。 近日,一项刊登于国际杂志Frontiers in Aging Neuroscience上的研究论文中,来自热那亚大学(University of

Nature:机体老化或影响黑色素瘤的疗法效应

随着机体老化,机体的细胞中会积累损伤同时出现慢性炎症发生,而随之而来的就是机体的癌症风险也会增加;近日刊登于国际著名杂志Nature上的一项研究论文中,来自美国宾夕法尼亚大学威斯达研究所(Wistar Institute)的研究人员通过研究发现,老化的黑色素肿瘤细胞或许在行为上与“年轻”的肿瘤细胞或许并不相同。 微环境的改变会使得老化的肿瘤细胞更加易于转移并且对靶向疗法更加耐受,而在某些研究发

美国FDA发布警告:两种糖尿病药物可能与心力衰竭风险增加相关联

美国卫生官员本周二警告道,含有沙格列汀(saxagliptin )和阿格列汀(alogliptin )的糖尿病药物可能提高心力衰竭风险,特别是对心脏病或肾病患者而言。美国FDA说,含有这些组分的药物是沙格列汀片(Onglyza)和盐酸沙格列汀(Kombiglyze XR,延长沙格列汀和二甲双胍释放)、阿格列汀片(Nesina)、Kazano(阿格列汀和二甲双胍)和Oseni(阿格列汀和吡格列

J Gen Physiol: 何时该排尿,膀胱有话说

佛蒙特大学医学院的研究人员的新发现,有助于解释我们如何知道什么时候该排空膀胱,并有助于发现膀胱功能性障碍治疗的新方法。 感知膀胱充盈看起来简单,肾脏将废物和多余的水分送到膀胱,直到达到它的充盈阈值,膀胱就告诉中枢神经系统:该排尿了。该研究小组领导者MarkNelson博士发现,除了充盈压力,过程中还有被称为"非排尿瞬时收缩(transientcontractions,TCs)"的膀胱平滑肌

Baidu
map
Baidu
map
Baidu
map